Ubs Group Ag Biolife Solutions Inc Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Biolife Solutions Inc stock. As of the latest transaction made, Ubs Group Ag holds 332,932 shares of BLFS stock, worth $8.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

332,932

Previous 14,930 2129.95%

Holding current value

$8.88 Million

Previous $373,000 2216.89%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$20.47 - $27.47 $6.51 Million - $8.74 Million	318,002 Added 2129.95%	332,932 $8.64 Million
Q3 2024 Nov 14, 2024	BUY	$19.19 - $26.52 $6,620 - $9,149	345 Added 2.37%	14,930 $373,000
Q2 2024 Aug 13, 2024	SELL	$15.14 - $22.99 $169,689 - $257,671	-11,208 Reduced 43.45%	14,585 $312,000
Q1 2024 May 13, 2024	SELL	$15.35 - $18.82 $49,534 - $60,732	-3,227 Reduced 11.12%	25,793 $478,000
Q4 2023 Feb 09, 2024	BUY	$8.99 - $16.86 $259,712 - $487,068	28,889 Added 22052.67%	29,020 $471,000
Q3 2023 Nov 09, 2023	SELL	$10.81 - $22.96 $302,182 - $641,823	-27,954 Reduced 99.53%	131 $1,000
Q2 2023 Aug 11, 2023	BUY	$17.19 - $24.34 $157,632 - $223,197	9,170 Added 48.48%	28,085 $620,000
Q1 2023 May 12, 2023	BUY	$17.67 - $26.07 $59,795 - $88,220	3,384 Added 21.79%	18,915 $411,000
Q4 2022 Feb 08, 2023	BUY	$16.95 - $25.07 $162,787 - $240,772	9,604 Added 162.04%	15,531 $282,000
Q3 2022 Nov 10, 2022	BUY	$14.64 - $26.7 $35,516 - $64,774	2,426 Added 69.29%	5,927 $135,000
Q2 2022 Aug 10, 2022	SELL	$10.54 - $24.2 $20,616 - $47,335	-1,956 Reduced 35.84%	3,501 $48,000
Q1 2022 May 16, 2022	SELL	$20.81 - $37.29 $106,880 - $191,521	-5,136 Reduced 48.48%	5,457 $123,000
Q4 2021 Feb 14, 2022	SELL	$32.99 - $58.55 $102,829 - $182,500	-3,117 Reduced 22.74%	10,593 $395,000
Q3 2021 Nov 15, 2021	BUY	$42.03 - $60.5 $384,112 - $552,909	9,139 Added 199.93%	13,710 $580,000
Q2 2021 Aug 13, 2021	SELL	$29.51 - $44.62 $542,157 - $819,758	-18,372 Reduced 80.08%	4,571 $204,000
Q1 2021 May 12, 2021	SELL	$32.95 - $44.24 $1.36 Million - $1.82 Million	-41,233 Reduced 64.25%	22,943 $826,000
Q4 2020 Feb 11, 2021	BUY	$27.5 - $45.75 $1.51 Million - $2.51 Million	54,882 Added 590.51%	64,176 $2.56 Million
Q3 2020 Nov 12, 2020	SELL	$16.04 - $28.94 $76,350 - $137,754	-4,760 Reduced 33.87%	9,294 $269,000
Q2 2020 Jul 31, 2020	SELL	$9.2 - $17.06 $16,422 - $30,452	-1,785 Reduced 11.27%	14,054 $230,000
Q1 2020 May 01, 2020	BUY	$8.36 - $17.03 $28,474 - $58,004	3,406 Added 27.39%	15,839 $151,000
Q4 2019 Feb 14, 2020	BUY	$14.59 - $18.9 $90,837 - $117,671	6,226 Added 100.31%	12,433 $201,000
Q3 2019 Nov 14, 2019	BUY	$15.7 - $20.98 $78,547 - $104,962	5,003 Added 415.53%	6,207 $104,000
Q2 2019 Aug 14, 2019	BUY	$15.2 - $19.42 $18,300 - $23,381	1,204 New	1,204 $20,000
Q4 2018 Feb 14, 2019	SELL	$9.5 - $17.17 $14,364 - $25,961	-1,512 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$14.99 - $25.48 $19,352 - $32,894	-1,291 Reduced 46.06%	1,512 $27,000
Q2 2018 Aug 14, 2018	BUY	$6.18 - $13.49 $4,838 - $10,562	783 Added 38.76%	2,803 $32,000
Q1 2018 May 15, 2018	BUY	$4.73 - $6.03 $9,554 - $12,180	2,020 New	2,020 $10,000
Q3 2017 Nov 14, 2017	SELL	$3.45 - $5.71 $462 - $765	-134 Closed	0 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-205 Reduced 60.47%	134 $0
Q1 2017 Nov 14, 2017	BUY	N/A	339	339 $1,000

Others Institutions Holding BLFS

# of Institutions

188

Shares Held

47.1M

Call Options Held

4.3K

Put Options Held

4.7K

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.14B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account